Umesh Alavadi

New Delhi, DL, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Establishing proof of concept for utility of Trueprep®-extracted DNA in line-probe assay testing.

Establishing proof of concept for utility of Trueprep®-extracted DNA in line-probe assay testing.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Published: September 26, 2023

Experience of "One Stop TB Diagnostic Solution" Model in Engaging a Private Laboratory for End-to-End Diagnostic Services in the National TB Elimination Program in Hisar, India.

Experience of "One Stop TB Diagnostic Solution" Model in Engaging a Private Laboratory for End-to-End Diagnostic Services in the National TB Elimination Program in Hisar, India.

Journal: Diagnostics (Basel, Switzerland)
Published: July 17, 2023

Comprehensive assessment of invalid and indeterminate results in Truenat MTB-RIF testing across sites under the national TB elimination program of India.

Comprehensive assessment of invalid and indeterminate results in Truenat MTB-RIF testing across sites under the national TB elimination program of India.

Journal: Frontiers in public health
Published: July 09, 2023

The Cost-Effectiveness of the BEAT-TB Regimen for Pre-Extensively Drug-Resistant TB.

The Cost-Effectiveness of the BEAT-TB Regimen for Pre-Extensively Drug-Resistant TB.

Journal: Tropical medicine and infectious disease
Published: June 30, 2023

Bedaquiline, Delamanid, Linezolid and Clofazimine for Treatment of Pre-extensively Drug-Resistant Tuberculosis.

Bedaquiline, Delamanid, Linezolid and Clofazimine for Treatment of Pre-extensively Drug-Resistant Tuberculosis.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: February 26, 2022

Strengthened capacity of India´s bedaquiline Conditional Access Programme for introducing new drugs and regimens.

Strengthened capacity of India´s bedaquiline Conditional Access Programme for introducing new drugs and regimens.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Published: October 31, 2020

Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India.

Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India.

Journal: PloS one
Published: December 02, 2014

Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB.

Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB.

Journal: PloS one
Published: April 17, 2014

Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India.

Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India.

Journal: PloS one
Published: September 16, 2013

Is bleach-sedimented smear microscopy an alternative to direct microscopy under programme conditions in India?

Is bleach-sedimented smear microscopy an alternative to direct microscopy under programme conditions in India?

Journal: Public health action
Published: December 15, 2012
Showing 1-10 of 10

Last Updated: 09/26/2026